Spring 2011

Blog on the YOCAS study from ASCO 2010.

A blog by Kathy LaTour, breast cancer survivor, on how hair loss affected her after cancer.

Ovarian cancer survivor, Annette Leal Mattern, offers up advice on living with metastatic disease.

Yoga videos from Yoga Bear, a nonprofit organization that offers yoga community to cancer patients and survivors.

Researchers make advances in scalp cooling to prevent hair loss.

Early trial shows botanical for advanced breast cancer ready for next step.

The website www.journeyforward.org was designed to help oncologists, primary care physicians and their patients improve their survivorship care.

ColoPrint gene assay can help guide treatment options for some colorectal patients, study shows.

Adolescents with AML tend to do better with stem cell transplant.

Letters from CURE readers.

An essay from a lung cancer survivor on how he copes with living with a hard-to-treat cancer.

Getting back to work after cancer can be intimidating, especially if complicated with symptoms of chemobrain.

The latest in cancer prevention, diagnosis and treatment.

States jump on the smoking ban wagon.

Brett Favre, Adam Levine and Pete Postlethwaite make cancer news.

Cancer Legal Resource Center offers free conferences.

Should Medicare pay for advance care planning?

Siddhartha Mukherjee, MD, PhD, has turned cancer into a page turner.

Reflecting on hair loss as a gift.

Yoga has earned accolades as a complementary therapy, and now studies are confirming its value.

Early planning can ease financial and insurance issues.

Modern medicine no longer relies on information just gleaned from under a microscope.

Nine simple steps you can start doing today.

The FDA's drug-approval process has several tracks that help medications quickly go from clinical research to clinical use.

A breakdown of different types of ovarian cancer.

Researchers are looking for effective screening methods for ovarian cancer.

There are many different types of yoga.

New research helps clarify what chemobrain is and why it happens. 

Patients and the FDA battle over Avastin's breast cancer indication.

Advances in ovarian cancer gain ground.